PL3619237T3 - Przeciwciała przeciwko antygenowi rakowo-płodowemu w terapii i diagnostyce nowotworów złośliwych - Google Patents

Przeciwciała przeciwko antygenowi rakowo-płodowemu w terapii i diagnostyce nowotworów złośliwych

Info

Publication number
PL3619237T3
PL3619237T3 PL18722497.7T PL18722497T PL3619237T3 PL 3619237 T3 PL3619237 T3 PL 3619237T3 PL 18722497 T PL18722497 T PL 18722497T PL 3619237 T3 PL3619237 T3 PL 3619237T3
Authority
PL
Poland
Prior art keywords
diagnosis
antibodies against
cancer therapy
carcinoembryonic antigen
against carcinoembryonic
Prior art date
Application number
PL18722497.7T
Other languages
English (en)
Inventor
Armelle Cuvillier
Gaël CHAMPIER
Original Assignee
B Cell Design
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B Cell Design filed Critical B Cell Design
Publication of PL3619237T3 publication Critical patent/PL3619237T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL18722497.7T 2017-05-04 2018-05-03 Przeciwciała przeciwko antygenowi rakowo-płodowemu w terapii i diagnostyce nowotworów złośliwych PL3619237T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17305498.2A EP3398967A1 (en) 2017-05-04 2017-05-04 Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis
PCT/EP2018/061385 WO2018202794A1 (en) 2017-05-04 2018-05-03 Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis

Publications (1)

Publication Number Publication Date
PL3619237T3 true PL3619237T3 (pl) 2024-06-24

Family

ID=58707444

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18722497.7T PL3619237T3 (pl) 2017-05-04 2018-05-03 Przeciwciała przeciwko antygenowi rakowo-płodowemu w terapii i diagnostyce nowotworów złośliwych

Country Status (10)

Country Link
US (1) US11427646B2 (pl)
EP (2) EP3398967A1 (pl)
AU (1) AU2018262648B2 (pl)
DK (1) DK3619237T5 (pl)
ES (1) ES2975798T3 (pl)
FI (1) FI3619237T3 (pl)
HU (1) HUE066183T2 (pl)
PL (1) PL3619237T3 (pl)
PT (1) PT3619237T (pl)
WO (1) WO2018202794A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025257185A1 (en) 2024-06-11 2025-12-18 Abcely Humanized anti-human-carcinoembryonic antigen antibody

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
FR2861255B1 (fr) 2003-10-24 2006-02-17 Centre Nat Rech Scient Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe a et ses applications.
EP2478110B1 (en) 2009-09-16 2016-01-06 Immunomedics, Inc. Class i anti-cea antibodies and uses thereof
US20140242081A1 (en) * 2011-07-18 2014-08-28 Micromet Ag Dosing regimens for treatment of cea-expressing cancers

Also Published As

Publication number Publication date
FI3619237T3 (fi) 2024-04-19
DK3619237T5 (da) 2024-09-02
EP3619237A1 (en) 2020-03-11
AU2018262648A1 (en) 2019-11-07
EP3619237B1 (en) 2024-01-17
WO2018202794A1 (en) 2018-11-08
HUE066183T2 (hu) 2024-07-28
PT3619237T (pt) 2024-03-05
US20200055952A1 (en) 2020-02-20
DK3619237T3 (da) 2024-04-08
CA3062233A1 (en) 2018-11-08
AU2018262648B2 (en) 2024-08-08
ES2975798T3 (es) 2024-07-15
EP3398967A1 (en) 2018-11-07
US11427646B2 (en) 2022-08-30

Similar Documents

Publication Publication Date Title
IL274246A (en) Methods for diagnosing and treating cancer
ZA202002923B (en) Cd47 antibodies and uses thereof for treating cancer
IL268396A (en) Diagnostic and therapeutic methods for cancer
IL248511A0 (en) Combined therapy for the treatment of cancer with a focovirus expressing the antigen and a monoclonal antibody against tim-3
IL265759A (en) Therapeutic and diagnostic methods for cancer
IL273071A (en) Treatment and diagnosis methods for cancer
IL264674B1 (en) Antibodies to siglec7 for cancer treatment
IL260474B (en) Antibodies specific to cadherin-17 and cytotoxic cells for cancer treatment
HUE061874T2 (hu) Anti-PD-1 antitestek és besugárzás kombinált alkalmazása a rák kezelésére
IL260935A (en) Methods for treating hrg, her2-, er breast cancer using combined treatments that include an anti-erbb3 antibody
IL277861A (en) Antibodies specific to AXL for cancer treatment
SI4339615T1 (sl) Protitelesa anti-pd-1 za uporabo pri zdravljenju raka
PT3512882T (pt) Anticorpos anti-c-met e conjugados anticorpo-fármaco dos mesmos para inibição tumoral eficaz
ZA202000851B (en) Antibodies useful in cancer diagnosis
IL281441B (en) Anti-cxcl13 antibodies for the treatment of autoimmune diseases and cancer
IL272669A (en) Combination therapy with a combination of anti-CSF1R and anti-PD-1 antibodies for pancreatic cancer
ZA202005023B (en) L2a5 antibody or functional fragment thereof against tumour antigens
SG11202005296SA (en) Combination therapy between anti-progastrin antibody and immunotherapy to treat cancer
GB201613167D0 (en) Cancer and b-cell related disease therapy
IL255273A0 (en) igf-1r antibody and its use for cancer diagnosis
HUE066183T2 (hu) Karcinoembrionális antigén elleni ellenanyagok rákterápiához és diagnosztizáláshoz
ZA201707247B (en) Igf-1r antibody and its use for the diagnosis of cancer
GB201813137D0 (en) Cancer treatment with an antibody
SG11202007750PA (en) Cancer antigen peptide
GB201813138D0 (en) Cancer treatment with an antibody